Table II.
Prevalence of US-detected findings in people with knee OA/pain
Number of studies | Number of subjects | Pooled prevalence (95% CI) | I2% (Pheter) | Ppub | |
---|---|---|---|---|---|
People with knee OA/pain | |||||
Effusion | 21 | 3266 | 51.5 (40.2–62.8) | 97.5 (<0.0001) | 0.082∗ |
Synovial hypertrophy | 13 | 1785 | 41.5 (26.3–57.5) | 97.6 (<0.0001) | 0.026∗ |
DS | 7 | 538 | 32.7 (8.34–63.24) | 98.0 (<0.0001) | 0.493∗ |
The general/normal population | |||||
Effusion | 6 | 922 | 19.9 (7.81–35.34) | 94.7 (<0.0001) | 0.587∗ |
Synovial hypertrophy | 4 | 601 | 14.5 (0–58.81) | 98.7 (<0.0001) | 0.118∗∗ |
DS | 2 | 533 | 15.8 (3.08–35.36) | 93.8 (<0.001) | – |
CI: confidence interval; I2: inconsistency; Pheter: p for heterogeneity; Ppub: p for publication bias.
Egger's test.
Harbord's test.